SCHEMBL4254141

SCHEMBL4254141

COc1cc2c(cc1-c1ccccc1)c1cc(-c3ccccc3)c(OC)cc1n2CCC(C)CCCC(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.39
ALDH1A1 P00352 2/20 0.39
KDM4E B2RXH2 1/20 0.39
RET P07949 1/20 0.35
POLB P06746 1/20 0.34
PSEN1 P49768 2/20 0.34
PSEN2 P49810 1/20 0.34
APH1B Q8WW43 1/20 0.34
NCSTN Q92542 1/20 0.34
APH1A Q96BI3 1/20 0.34
PSENEN Q9NZ42 1/20 0.34
CASR P41180 1/20 0.34
PGR P06401 2/20 0.33
APLNR P35414 1/20 0.33
PDE5A O76074 2/20 0.33
RXFP1 Q9HBX9 1/20 0.33
ACACA Q13085 1/20 0.33
MEN1 O00255 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4267403 0.90 MAPT (0.39) MAPTALDH1A1KDM4EPOLBPSEN1
SCHEMBL4261403 0.88 MAPT (0.43) MAPTALDH1A1KDM4EPOLBPSEN1
SCHEMBL4267934 0.82 MAPT (0.42) MAPTALDH1A1KDM4EPOLBPSEN1
SCHEMBL4254129 0.82 HTR2A (0.35) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL4260558 0.77 PSEN1 (0.43) MAPTALDH1A1POLBPSEN1PSEN2
SCHEMBL13656489 0.77 PSEN1 (0.55) MAPTKDM4EPSEN1PSEN2APH1B
SCHEMBL4976507 0.75 CSF1R (0.35) PSEN1
SCHEMBL4267408 0.74 MAPT (0.32) MAPTALDH1A1KDM4EPOLBPSEN1
SCHEMBL5999369 0.72 MAPT (0.49) MAPTALDH1A1KDM4EPOLBMEN1
SCHEMBL4267813 0.71 SIGMAR1 (0.38) MAPTALDH1A1POLBPSEN1PSEN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090242876-A1 CARBAZOLE COMPOUNDS KONINKLIJKE PHILIPS ELECTRONICS, N.V. (NL) 2009-10-01 US disclosed
EP-1838671-B1 9,9'- AND 2,2'-SUBSTITUTED 3,3'-BICARBAZOLYL DERIVATIVES FOR USE IN SEMICONDUCTING MATERIALS AS A HOST MATRIX FOR PHOSPHORESCENT EMITTERS KONINKL PHILIPS ELECTRONICS NV (NL) 2008-06-04 EP disclosed
EP-1838671-A2 9,9'- AND 2,2'-SUBSTITUTED 3,3'-BICARBAZOLYL DERIVATIVES FOR USE IN SEMICONDUCTING MATERIALS AS A HOST MATRIX FOR PHOSPHORESCENT EMITTERS Koninklijke Philips Electronics N.V. (NL) 2007-10-03 EP disclosed
WO-2006061759-A2 9 , 9 ' - AND 2 , 2 ' -SUBSTITUTED 3 , 3 ' -BICARBAZOLYL DERIVATIVES FOR USE IN SEMICONDUCTING MATERIALS AS A HOST MATRIX FOR PHOSPHORESCENT EMITTERS KONINKLIJKE PHILIPS ELECTRONICS N.V. (NL) 2006-06-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090242876-A1 CARBAZOLE COMPOUNDS CCNI, IL33, PAICS MAPT 2051/4885ALDH1A1 1152/4885KDM4E 3143/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.